BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7916782)

  • 21. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H; Jiang P; Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basement membrane components and keratin in the dominantly inherited form of cylindroma.
    Oikarinen A; Peltonen L
    Acta Derm Venereol; 1985; 65(2):121-5. PubMed ID: 2408413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx.
    Nerlich AG; Lebeau A; Hagedorn HG; Sauer U; Schleicher ED
    Anticancer Res; 1998; 18(5A):3515-20. PubMed ID: 9858933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basement membrane component changes in skeletal muscle transplants undergoing regeneration or rejection.
    Gulati AK
    J Cell Biochem; 1985; 27(4):337-46. PubMed ID: 3997979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva.
    Fukuda K; Chikama T; Nakamura M; Nishida T
    Cornea; 1999 Jan; 18(1):73-9. PubMed ID: 9894941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histological and immunohistochemical study of pars tensa retraction pocket.
    Shunyu NB; Gupta SD; Thakar A; Sharma SC
    Otolaryngol Head Neck Surg; 2011 Oct; 145(4):628-34. PubMed ID: 21593461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alterations of the basal membrane in middle ear cholesteatoma].
    Bernal Sprekelsen M; Ebmeyer J; Anonopoulos A; Borkowski G; Sudhoff H
    Acta Otorrinolaringol Esp; 2001 May; 52(4):330-5. PubMed ID: 11526629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver.
    Martinez-Hernandez A
    Lab Invest; 1984 Jul; 51(1):57-74. PubMed ID: 6376944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Basement membranes and tumor pathology].
    Birembaut P; Caron Y; Loiseaux F; Adnet JJ
    Bull Cancer; 1984; 71(5):468-73. PubMed ID: 6395922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of basement membrane-associated heparan sulfate proteoglycan in idiopathic and AIDS-associated Kaposi's sarcoma.
    Nerlich A; Zietz C; Schleicher E
    Pathol Res Pract; 1991 May; 187(4):444-50. PubMed ID: 1876526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the distribution of laminin, fibronectin, type IV collagen and heparan sulfate proteoglycan during colony formation by chick retinal pigment epithelial cells in vitro.
    Turksen K; Aubin JE; Sodek J; Kalnins VI
    Coll Relat Res; 1984 Dec; 4(6):413-26. PubMed ID: 6241122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components.
    Form DM; Pratt BM; Madri JA
    Lab Invest; 1986 Nov; 55(5):521-30. PubMed ID: 2430138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of a supramolecular complex is involved in the reconstitution of basement membrane components.
    Kleinman HK; McGarvey ML; Hassell JR; Martin GR
    Biochemistry; 1983 Oct; 22(21):4969-74. PubMed ID: 6227336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of basement membrane formation by a nidogen-binding laminin gamma1-chain fragment in human skin-organotypic cocultures.
    Breitkreutz D; Mirancea N; Schmidt C; Beck R; Werner U; Stark HJ; Gerl M; Fusenig NE
    J Cell Sci; 2004 May; 117(Pt 12):2611-22. PubMed ID: 15159456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of type IV collagen, laminin, heparan sulfate proteoglycan, and fibronectin to the basal lamina of basement membranes.
    Laurie GW; Leblond CP; Martin GR
    J Cell Biol; 1982 Oct; 95(1):340-4. PubMed ID: 6216257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autocrine growth mechanisms of cholesteatoma epithelium].
    Schilling V; Holly A; Bujía J; Schulz P
    Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis.
    Westermark GT; Norling B; Westermark P
    Clin Exp Immunol; 1991 Oct; 86(1):150-6. PubMed ID: 1914228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
    Holly A; Sittinger M; Bujía J
    Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proliferation behavior of cholesteatoma].
    Hoppe F
    HNO; 1995 Dec; 43(12):710-5. PubMed ID: 8582830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basement membrane in Kaposi's sarcoma: an immunohistochemical and ultrastructural study.
    Bendelac A; Kanitakis J; Chouvet B; Thivolet J
    Pathol Res Pract; 1985 Dec; 180(6):626-32. PubMed ID: 3913949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.